BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18235085)

  • 1. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R; Pianetti G; Gautard R; Misselwitz J; Strain L; Fremeaux-Bacchi V; Skerka C; Zipfel PF; Goodship T; Noris M; Remuzzi G; de Cordoba SR;
    J Am Soc Nephrol; 2008 Mar; 19(3):639-46. PubMed ID: 18235085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
    Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.
    Sánchez-Corral P; Pérez-Caballero D; Huarte O; Simckes AM; Goicoechea E; López-Trascasa M; de Córdoba SR
    Am J Hum Genet; 2002 Dec; 71(6):1285-95. PubMed ID: 12424708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity.
    Blom AM; Bergström F; Edey M; Diaz-Torres M; Kavanagh D; Lampe A; Goodship JA; Strain L; Moghal N; McHugh M; Inward C; Tomson C; Frémeaux-Bacchi V; Villoutreix BO; Goodship TH
    J Immunol; 2008 May; 180(9):6385-91. PubMed ID: 18424762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.
    Ermini L; Goodship TH; Strain L; Weale ME; Sacks SH; Cordell HJ; Fremeaux-Bacchi V; Sheerin NS
    Mol Immunol; 2012 Jan; 49(4):640-8. PubMed ID: 22153652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E; Westra D; Xue X; Gros P; van de Kar N; van den Heuvel L
    Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.
    Sullivan M; Erlic Z; Hoffmann MM; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Rybicki LA; Bock A; Berisha G; Neumann HP
    Ann Hum Genet; 2010 Jan; 74(1):17-26. PubMed ID: 20059470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.
    Recalde S; Tortajada A; Subias M; Anter J; Blasco M; Maranta R; Coco R; Pinto S; Noris M; García-Layana A; Rodríguez de Córdoba S
    J Am Soc Nephrol; 2016 May; 27(5):1305-11. PubMed ID: 26376859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy.
    Wilson V; Darlay R; Wong W; Wood KM; McFarlane J; Schejbel L; Schmidt IM; Harris CL; Tellez J; Hunze EM; Marchbank K; Goodship JA; Goodship TH
    Am J Kidney Dis; 2013 Nov; 62(5):978-83. PubMed ID: 23870792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.